Background Trial Intervention

https://w3id.org/m11-rdf/C217347.C222329

Definition
Description of medicinal products that are administered to each clinical trial participant, regardless of randomisation group, a) to treat the indication which is the object of the study, or b) required in the protocol as part of standard care for a condition that is not the indication under investigation, and is relevant for the clinical trial design. (CDISC Glossary)
Namespace
ICH M11 Section 6 Terminology
ICH pair
2.16.840.1.113883.3.989.2.3.3.6 + C222329 (derived from the ToC section)
NCIt concept
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C222329 (EVS identifier)
NCIT_C222329 (OBO PURL)
EVS term
http://rdf.ich.org/ich-terminology#C217347.C222329 (EVS term IRI; does not resolve)
Label from
ICH M11 Terminology, NCI EVS, release 2025-12-19

Specifications in the Technical Specification

One row per component block of Appendix 1 that names this element. Text as printed.

BlockTermSectionConformanceCardinalityData typeValue code listRepeating / reuse
346{<Background Trial Intervention>}6.9.1 Background Trial InterventionConditional: when any background interventions are definedOne to oneText (D)No

In the ICH M11 Template

The Template heading of 6.9.1 Background Trial Intervention is this element.

SectionFieldTemplatePageLinked by
6.9.1 Background Trial Intervention 6.9.1<Enter Background Trial Intervention>conditionalp. 41ts-term / verb-dropped / section

Mapping statements to USDM v4

None: no row of the two pinned mappings is identified with this element and resolves in USDM v4.0.0.

Draft, not normative. A derived rendering of the ICH M11 Technical Specification, Template, code lists and OID Listing (© ICH, used under the ICH Legal Mentions) and of the ICH M11 Terminology published by NCI EVS (CC BY 4.0). Not an ICH, CDISC or HL7 artifact, and not endorsed or sponsored by ICH.